Answers are grounded in this paper and cite their sources.
Background: Perfluorooctane sulfonic acid (PFOS) is a ubiquitous industrial chemical linked to cardiovascular toxicity. Quercetin, a plant-derived flavonoid, exhibits known anti-inflammatory properties. While PFOS induces endothelial dysfunctions, the molecular mechanisms underlying quercetin’s protective effects remain unclear. Methods: We integrated transcriptomic analysis and in vitro experiments to investigate these mechanisms in human microvascular endothelial cells (HMEC-1). Results: Five overlapping hub genes between PFOS and quercetin targets (IL6, RELA, VEGFA, CXCL8 and PIM1) were identified. Enrichment and protein–protein interaction network analyses showed the AGE–RAGE signaling pathway and cytokine activity as primary mediators. Furthermore, these five hub genes were significantly up-regulated in human atheromatous plaque tissues (GSE43292). Crucially, an independent external validation using a Logistic Regression machine learning model on an external dataset (GSE100927) demonstrated the strong predictive power of these five overlapping hub genes (AUC = 0.82) in classifying atherosclerotic lesions, effectively mitigating internal validation bias and strongly supporting their clinical diagnostic relevance. To verify these findings, we demonstrated that PFOS exposure induced p65 phosphorylation, up-regulated VEGFA and ICAM1, and down-regulated SIRT1 and SOCS3 expression in HMEC-1 cells. Quercetin co-treatment effectively reversed these molecular alterations, suppressing p65 phosphorylation and VEGFA/ICAM1 expression, while restoring SIRT1 and SOCS3 levels. Conclusions: These findings provide novel insights into how quercetin alleviates PFOS-induced inflammatory responses associated with endothelial activation.
No takes yet. Share an insight, caveat, or question.
Vajeethaveesin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: